{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:24:22Z","timestamp":1790900662486,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.tripleo.2009.07.035","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T04:41:06Z","timestamp":1255668066000},"page":"e1-e10","source":"Crossref","is-referenced-by-count":31,"title":["Inflammatory bowel disease"],"prefix":"10.1016","volume":"108","author":[{"given":"Mahnaz","family":"Fatahzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2009.07.035_bib1","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.3748\/wjg.14.5491","article-title":"Inflammatory bowel diseases: A disease(s) of modern times? Is incidence still increasing?","volume":"14","author":"Gismera","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib2","series-title":"Harrison's principles of internal medicine","first-page":"1777","article-title":"Inflammatory bowel disease","author":"Friedman","year":"2008"},{"key":"10.1016\/j.tripleo.2009.07.035_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0720-048X(00)00238-2","article-title":"The epidemiology and the pathogenesis of inflammatory bowel disease","volume":"35","author":"Karlinger","year":"2000","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0016-5107(04)02200-X","article-title":"Gastroduodenal Crohn's disease","volume":"60","author":"Fix","year":"2004","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.tripleo.2009.07.035_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1745-7599.2007.00242.x","article-title":"Clinical review of Crohn's disease","volume":"19","author":"Ruthruff","year":"2007","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.tripleo.2009.07.035_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/adc.2007.128751","article-title":"Crohn's disease: current treatment options","volume":"93","author":"Akobeng","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tripleo.2009.07.035_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/003655200451207","article-title":"Concordance of inflammatory bowel disease among Danish twins","volume":"35","author":"Orholm","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/gut.29.7.990","article-title":"Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins","volume":"29","author":"Tysk","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0031-3955(05)70405-3","article-title":"Crohn's disease in children","volume":"43","author":"Hyams","year":"1996","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.tripleo.2009.07.035_bib10","series-title":"Textbook of gastroenterology","first-page":"1775","article-title":"Inflammatory bowel disease","author":"Stenson","year":"1999"},{"key":"10.1016\/j.tripleo.2009.07.035_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.39.5.690","article-title":"Incidence of inflammatory bowel disease across Europe: is there a difference between north and south?","volume":"39","author":"Shivananda","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1572-0241.2006.00603.x","article-title":"The epidemiology of Inflammatory Bowel Disease in Canada: a population-based study","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1572-0241.2006.00552.x","article-title":"Increasing incidences of Inflammatory Bowel Disease and decreasing surgery rates in Copenhagen city and Country, 2003-2005: a population-based study from the Danish Crohn's Colitis database","volume":"101","author":"Vind","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of Inflammatory Bowel Disease: incidence, prevalence and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tripleo.2009.07.035_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1751-2980.2007.00310.x","article-title":"Inflammatory bowel disease: progress and current concepts of etiopathogenesis","volume":"8","author":"Scaldaferri","year":"2007","journal-title":"J Dig Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib17","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11605-008-0661-1","article-title":"Fulminant colitis","volume":"12","author":"Sands","year":"2008","journal-title":"J Gastrointestinal Surg"},{"key":"10.1016\/j.tripleo.2009.07.035_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","article-title":"Inflammatory bowel disease","volume":"334","author":"Hanauer","year":"1996","journal-title":"N Eng J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(01)00002-4","article-title":"Epidemiology of inflammatory bowel disease","volume":"31","author":"Loftus","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.tripleo.2009.07.035_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1572-0241.2006.00632.x","article-title":"Possible association between isotretinoin and inflammatory bowel disease","volume":"101","author":"Reddy","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1572-0241.1998.083_c.x","article-title":"Fecal hydrogen sulfide production in ulcerative colitis","volume":"93","author":"Levine","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib25","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/BF01536701","article-title":"A meta-analysis of the role of smoking in inflammatory bowel disease","volume":"34","author":"Calkins","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tripleo.2009.07.035_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2125.1999.00039.x","article-title":"Nicotine treatment for ulcerative colitis","volume":"48","author":"Guslandi","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology","volume":"96","author":"Hanauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00042737-200606000-00005","article-title":"Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002","volume":"18","author":"Jacobsen","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ibd.20321","article-title":"Incidence of inflammatory bowel disease in Malta between 1993 and 2005: a retrospective study","volume":"14","author":"Cachia","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11938-003-0001-1","article-title":"Treatment of Crohn's disease of inflammatory, stenotic and fistulizing phenotypes","volume":"6","author":"Dubinsky","year":"2003","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.0105-2896.2005.00293.x","article-title":"Defects in mucosal immunity leading to Crohn's disease","volume":"206","author":"Cobrin","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tripleo.2009.07.035_bib33","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.3748\/wjg.v12.i42.6751","article-title":"Crohn's disease: innate immunodeficiency?","volume":"12","author":"Yamamoto-Furusho","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.10368","article-title":"Isotretinoin-induced inflammatory bowel disease in an adolescent","volume":"35","author":"Reniers","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.tripleo.2009.07.035_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bpg.2003.12.003","article-title":"Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice","volume":"18","author":"Cosnes","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2005.02424.x","article-title":"Review article: smoking cessation as a primary therapy to modify the course of Crohn's disease","volume":"21","author":"Johnson","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib37","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2004.02.072","article-title":"From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation","volume":"126","author":"Sands","year":"2004","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.tripleo.2009.07.035_bib38","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1016\/S1590-8658(08)60539-3","article-title":"The multidisciplinary team for management of inflammatory bowel diseases","volume":"40","author":"Ricci","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cgh.2006.02.003","article-title":"Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease","volume":"4","author":"Chamouard","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2036.2003.01482.x","article-title":"Review article: nutrition and adult inflammatory bowel disease","volume":"17","author":"Goh","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib41","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jcp.50.2.93","article-title":"Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease","volume":"50","author":"Jenkins","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gut.13.12.970","article-title":"The size and histological appearance of mesenteric lymph nodes in Crohn's disease","volume":"13","author":"Cook","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1572-0241.2006.00506.x","article-title":"A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease","volume":"101","author":"Triester","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0889-8553(01)00007-3","article-title":"Radiographic imaging of inflammatory bowel disease","volume":"31","author":"Carucci","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.tripleo.2009.07.035_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1148\/radiol.2381050296","article-title":"Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy","volume":"238","author":"Hara","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.tripleo.2009.07.035_bib47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gut.2005.076612","article-title":"New diagnostic imaging tools for inflammatory bowel disease","volume":"55","author":"MacKalski","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1572-0241.2003.07521.x","article-title":"Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study","volume":"98","author":"Maconi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 5","key":"10.1016\/j.tripleo.2009.07.035_bib49","doi-asserted-by":"crossref","first-page":"V10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib50","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"Ullman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tripleo.2009.07.035_bib51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment Pharmacother"},{"key":"10.1016\/j.tripleo.2009.07.035_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/adc.2007.128751","article-title":"Crohn's disease: current treatment options","volume":"93","author":"Akobeng","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tripleo.2009.07.035_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1443-9573.2007.00287.x","article-title":"Management of inflammatory bowel disease in adults","volume":"8","author":"Katz","year":"2007","journal-title":"J Dig Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00148581-200608050-00002","article-title":"Current therapy of inflammatory bowel disease in children","volume":"8","author":"Rufo","year":"2006","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.tripleo.2009.07.035_bib55","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v12.i30.4794","article-title":"Conventional therapy for Crohn's disease","volume":"12","author":"Buning","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3949\/ccjm.69.8.621","article-title":"Inflammatory bowel disease: sorting out treatment options","volume":"69","author":"Wolf","year":"2002","journal-title":"Cleveland Clin J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.14.354","article-title":"Treatment of inflammatory bowel disease: a review of medical therapy","volume":"14","author":"Kozuch","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib58","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1046\/j.1365-2036.2002.01289.x","article-title":"The effectiveness of budesonide therapy for Crohn's disease","volume":"16","author":"Kane","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn's disease","volume":"123","author":"Pearson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib60","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib62","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib64","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib65","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for maintenance of remission in Crohn's disease","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib66","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001574-200107000-00002","article-title":"Mechanism of tissue damage in inflammatory bowel disease","volume":"17","author":"Pallone","year":"2001","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib67","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-alpha for Crohn's disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib68","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinthera.2008.02.014","article-title":"A review of infliximab use in ulcerative colitis","volume":"30","author":"Wilhelm","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib70","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/07853890108995961","article-title":"Thalidomide for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature","volume":"33","author":"Ginsburg","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib71","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1600-0714.2007.00430.x","article-title":"The management of fistulizing oral Crohn's disease with infliximab","volume":"36","author":"Staines","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/moe.2002.113","article-title":"Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis","volume":"95","author":"Hegarty","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2009.07.035_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","article-title":"Thalidomide: current and potential clinical applications","volume":"108","author":"Calabrese","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib74","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2009.07.035_bib75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2036.2008.03757.x","article-title":"Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis","volume":"28","author":"Pastorelli","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib76","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1572-0241.1999.01143.x","article-title":"Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease","volume":"94","author":"Folwaczny","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib77","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.1997.00252.x","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with heparin\u2014a report of 16 cases","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2009.07.035_bib78","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF01536795","article-title":"Testing nicotine gum for ulcerative colitis patients: experience with single patient trials","volume":"35","author":"Lashner","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tripleo.2009.07.035_bib79","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib80","first-page":"13","article-title":"Growth failure in children and adolescents with Crohn's disease","volume":"20","author":"Tietjen","year":"2009","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib81","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0300-2977(96)00064-2","article-title":"Problems in diagnosis of IBD in children","volume":"50","author":"Buller","year":"1997","journal-title":"Netherland J Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib82","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1079\/PNS2003287","article-title":"Surgical management of intestinal failure","volume":"62","author":"Carlson","year":"2003","journal-title":"Proc Nutr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2009.07.035_bib83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MPG.0b013e3181819007","article-title":"Overview of pediatric short bowel syndrome","volume":"47","author":"Duro","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.tripleo.2009.07.035_bib84","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extra-intestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","article-title":"Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study","volume":"10","author":"Ricart","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib86","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tripleo.2009.07.035_bib87","first-page":"297","article-title":"Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis","volume":"125","author":"Mendoza","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.tripleo.2009.07.035_bib88","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib89","first-page":"185","article-title":"Cutaneous manifestations of ulcerative colitis","volume":"15","author":"Areias","year":"1987","journal-title":"Med Cutan Ibero Lat Am"},{"key":"10.1016\/j.tripleo.2009.07.035_bib90","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients","volume":"87","author":"Farhi","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.tripleo.2009.07.035_bib91","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0733-8635(02)00014-1","article-title":"Cutaneous manifestations of gastrointestinal diseases","volume":"20","author":"Boh","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.tripleo.2009.07.035_bib92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0300-5089(21)00451-X","article-title":"Oral manifestations of inflammatory bowel disease","volume":"9","author":"Basu","year":"1980","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clindermatol.2007.10.018","article-title":"Skin manifestations of inflammatory bowel disease","volume":"26","author":"Timani","year":"2008","journal-title":"Clin Dermatol"},{"issue":"2 Pt 2","key":"10.1016\/j.tripleo.2009.07.035_bib94","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0190-9622(94)70167-9","article-title":"Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease","volume":"31","author":"Storwick","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib95","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0030-4220(91)90012-2","article-title":"Pyostomatitis vegetans: oral manifestation of ulcerative colitis","volume":"72","author":"Chan","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib96","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0030-4220(83)90191-3","article-title":"The differential diagnosis of pyostomatitis vegetans and its relation to bowel disease","volume":"55","author":"Hansen","year":"1983","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib97","first-page":"1033","article-title":"Metastatic Crohn's disease: a review","volume":"22","author":"Palamaras","year":"2008","journal-title":"JEADV"},{"key":"10.1016\/j.tripleo.2009.07.035_bib98","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1542-3565(05)00424-6","article-title":"A prospective study of the oral manifestations of Crohn's disease","volume":"3","author":"Harty","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine"},{"key":"10.1016\/j.tripleo.2009.07.035_bib100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1067\/mpd.2001.113008","article-title":"The oral cavity in Crohn's disease","volume":"138","author":"Pittock","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.tripleo.2009.07.035_bib101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0030-4220(78)90198-6","article-title":"Oral lesions in Crohn's disease: report of two cases and update of the literature","volume":"46","author":"Berstein","year":"1978","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1875-595X.2002.tb00622.x","article-title":"Oral aspects of Crohn's disease","volume":"52","author":"Scheper","year":"2002","journal-title":"Int Dent J"},{"key":"10.1016\/j.tripleo.2009.07.035_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199102000-00008","article-title":"Oral manifestations of Crohn's disease","volume":"13","author":"Plauth","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib104","first-page":"A388","article-title":"The prevalence of oral manifestations of inflammatory bowel disease in a paediatric population","volume":"73","author":"Barnard","year":"1994","journal-title":"J Dent Res"},{"key":"10.1016\/j.tripleo.2009.07.035_bib105","first-page":"1258","article-title":"Stomatological manifestations of Crohn's disease","volume":"49","author":"Gabioud","year":"1999","journal-title":"Rev Prat"},{"key":"10.1016\/j.tripleo.2009.07.035_bib106","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1902\/jop.2002.73.12.1512","article-title":"Pyostomatitis vegetans as an early sign of reactivation of Crohn's disease: a case report","volume":"73","author":"Ayangco","year":"2002","journal-title":"J Periodontol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000068900","article-title":"Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent","volume":"206","author":"Bogenrieder","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.tripleo.2009.07.035_bib108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1542\/peds.2004-2281","article-title":"Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings","volume":"116","author":"Galbraith","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.tripleo.2009.07.035_bib109","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.135.4.439","article-title":"Oral Crohn's disease: clinical characteristics and long-term follow-up of 9 cases","volume":"135","author":"Dupuy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0030-4220(93)90200-N","article-title":"Oral findings in patients with active or inactive Crohn's disease","volume":"76","author":"Halme","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib111","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(81)70130-0","article-title":"Cutaneous manifestations of Crohn's disease","volume":"5","author":"Burgdorf","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib112","doi-asserted-by":"crossref","unstructured":"Sangueza OP, Davis LS, Gourdin FW. Metastatic Crohn's disease. South Med J 997;90:897-900.","DOI":"10.1097\/00007611-199709000-00006"},{"key":"10.1016\/j.tripleo.2009.07.035_bib113","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s10620-006-9533-2","article-title":"Metastatic Crohn's disease of the face","volume":"51","author":"Graham","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tripleo.2009.07.035_bib114","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0190-9622(84)80038-9","article-title":"Metastatic Crohn's disease","volume":"10","author":"Lebwohl","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00054725-200203000-00006","article-title":"Metastatic Crohn's disease of the forehead","volume":"8","author":"Biancone","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1540-9740.2007.05907.x","article-title":"Crohn's disease and its mucocutaneous involvement [review]","volume":"694","author":"Ruocco","year":"2007","journal-title":"Skin Med"},{"key":"10.1016\/j.tripleo.2009.07.035_bib117","article-title":"Severe refractory orofacial Crohn's disease: report of a case","author":"Quezada","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tripleo.2009.07.035_bib118","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.joms.2003.06.003","article-title":"Salivary duct fistula and recurrent buccal space infection: a complication of Crohn's disease","volume":"61","author":"Mills","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2009.07.035_bib119","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/pmj.76.901.713","article-title":"Sweet's syndrome in association with Crohn's disease","volume":"76","author":"Vaz","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.tripleo.2009.07.035_bib120","first-page":"874","article-title":"Extraintestinal complications in patients with ulcerative colitis","volume":"63","author":"Oshitani","year":"2005","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.tripleo.2009.07.035_bib121","first-page":"143","article-title":"Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazo-sulfapyridine","volume":"8","author":"Pironi","year":"1988","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.tripleo.2009.07.035_bib122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2230.1997.1930606.x","article-title":"Pellagra, azathioprine and inflammatory bowel disease","volume":"22","author":"Jarrett","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib123","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0899-9007(96)91118-1","article-title":"Nutritional considerations and management of the child with inflammatory bowel disease","volume":"12","author":"Oliva","year":"1996","journal-title":"Nutrition"},{"key":"10.1016\/j.tripleo.2009.07.035_bib124","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/adc.2005.080481","article-title":"Inflammatory bowel disease","volume":"91","author":"Beattie","year":"2006","journal-title":"Arch Dise Child"},{"key":"10.1016\/j.tripleo.2009.07.035_bib125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/00365529609094750","article-title":"Nutrition and gastrointestinal disease","volume":"220","author":"O'Keefe","year":"1996","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.tripleo.2009.07.035_bib126","first-page":"201","article-title":"Selecting topical and systemic agents for recurrent aphthous stomatitis","volume":"68","author":"Eisen","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.tripleo.2009.07.035_bib127","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00015550152384290","article-title":"Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low dose prednisolone","volume":"81","author":"Brinkmeier","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1985.01660010098029","article-title":"Pyostomatitis vegetans","volume":"12","author":"VanHale","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2004.11.041","article-title":"Treatment of pyostomatitis vegetans with topical tacrolimus","volume":"52","author":"Werchniak","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib130","first-page":"352","article-title":"Oral manifestations in Crohn's disease: report of a case","volume":"80","author":"Estrin","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02825488","article-title":"Crohn's disease presenting as palatal ulcer","volume":"73","author":"Ganesh","year":"2006","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.tripleo.2009.07.035_bib132","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/00365520510023512","article-title":"Treatment-resistant lingual Crohn's disease disappears after infliximab","volume":"40","author":"Brunner","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib133","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/moe.2002.113","article-title":"Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis","volume":"95","author":"Hegarty","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2009.07.035_bib134","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00005176-199902000-00025","article-title":"Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease","volume":"28","author":"Weinstein","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.tripleo.2009.07.035_bib135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.47.3.436","article-title":"Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease","volume":"47","author":"Casson","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.tripleo.2009.07.035_bib136","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1572-0241.2008.02094_16.x","article-title":"Oral Crohn's disease: a favorable clinical response with delayed-release triamcinolone acetonide intralesional injections","volume":"103","author":"Mignogna","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib137","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0190-9622(85)80033-5","article-title":"Oral Crohn's disease: report of two cases in brothers with metallic dysgeusia and a review of the literature","volume":"12","author":"Frankel","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2009.07.035_bib138","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2036.2003.01782.x","article-title":"Review article: oral ulceration\u2014aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic","volume":"18","author":"Field","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409004867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210409004867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T08:47:28Z","timestamp":1634028448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210409004867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1079210409004867"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2009.07.035","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}